24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Long-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major JournalData Doesn't Support Need for COVID-19 Vaccine Boosters: ExpertsCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterMonth-Long Recovery From Concussion Is Normal: StudyDeath From COVID 11 Times More Likely If You're Unvaccinated: StudyL.A. Is First Major School District to Mandate Vaccines for Students 12 and UpNew Tally Adds Extra 16,000 U.S. Nursing Home Residents Lost to COVIDBlack Americans, Mexican Americans Develop Diabetes Earlier in LifeAverage COVID Hospitalization Is 150 Times More Expensive Than VaccinationGetting Your First COVID Shot Can Boost Mental Health: StudyVaccinated Have 1 in 13,000 Chance of Breakthrough Case Needing HospitalizationBiden Issues Tough New Vaccine Mandates Affecting Millions of U.S. WorkersTime Is Brain: Mobile Stroke Units Reduce Disability, Study FindsWildfires Cause More Than 33,000 Deaths Globally Each YearIs Your Workplace an Asthma Trigger?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanAHA News: How a Simple Tape Measure May Help Predict Diabetes in Black AdultsEczema Can Take Toll on Child's Mental HealthNo Lasting Damage to Lungs After COVID in Young Patients: StudyAdults With Autism, Mental Illness May Be at Higher Risk for Severe COVIDIn Cancer Patients, COVID Vaccine Immunity at 6 Months Is Similar to General PopulationNew Insights Into Why Asthma Worsens at NightHere's How COVID-19 Can Affect Your MouthPet Dogs Can Alert Owners to Epileptic SeizuresU.S. COVID-19 Cases Now Top 40 MillionWhy Aren't COVID Vaccines Getting to People Globally?
Questions and AnswersLinks
Related Topics

Diabetes

Eczema Can Take Toll on Child's Mental Health

HealthDay News
by By Alan Mozes HealthDay Reporter
Updated: Sep 8th 2021

new article illustration

WEDNESDAY, Sept. 8, 2021 (HealthDay News) -- Eczema doesn't just irritate kids' skin. The often disfiguring condition may also be tied to depression, anxiety and sleep difficulties, new research warns.

A study of more than 11,000 British children and teens found that those with severe eczema were twice as likely to become clinically depressed as eczema-free kids.

"Eczema is an itchy red skin disease," said study author Dr. Katrina Abuabara, an associate professor of dermatology at the University of California, San Francisco.

But it's complex.

"The disease course and severity can be quite variable," explained Abuabara. "It often presents in early childhood, but can occur at any age. It tends to be episodic, flaring up, then remitting, but these cycles can be chronic over years.

"For many children, the disease seems to improve by their teen years, but we've found that some continue to have episodic disease into adulthood," she added.

Risk goes up among those with a family history of the disease or related conditions like asthma and allergies. And the condition "is quite common, affecting up to 20% of kids and 10% of adults," Abuabara noted.

Among the children she and her colleagues started tracking in 1991, the annual prevalence of eczema -- also known as atopic dermatitis -- ranged from 14% to 19% between the ages of 3 and 18.

Roughly 22% to 40% developed a moderate or severe form of the disease; the rest of the cases were mild.

In addition to being linked to a doubling of depression risk, severe eczema also doubled the risk for the kind of depressive and/or anxiety-linked behaviors that typically indicate underlying emotional and psychological difficulties. Severe cases also drove up the odds for sleep troubles.

The depressed children were more likely to be female, and from a higher social class, the authors found.

Mild and moderate eczema were not linked to a higher risk for childhood depression, the team stressed. But among children as young as 4, even less serious cases of eczema were associated with a 29% to 84% spike in the risk for internalizing behaviors.

That's concerning, Abuabara and her colleagues noted, because children who struggle with depression and/or brewing emotional turmoil may face a higher risk for depression, anxiety and poor overall health as adults.

"Many parents of children with eczema will tell you it can be a deceptively devastating disease," Abuabara said.

"Eczema has long been known to cause sleep disturbances which impact the whole family," she added, "and certainly can take a toll on emotional well-being. Increasingly, studies are revealing that some types of eczema are more than 'skin deep', and can impact overall health in a variety of ways."

In general, "skin disease is well known to affect patients' quality of life and cause depression," agreed Dr. Robert Kirsner, chairman of the department of dermatology and cutaneous surgery at the University of Miami Miller School of Medicine.

Children are often thought to be relatively resilient in that respect, said Kirsner, who was not part of the study team.

But "understandably, severe eczema, even in children, can cause depression and associated internalizing symptoms such as low self-esteem, fear and worrying," he said.

Of note is the finding that even "less severely affected patients apparently are emotionally affected by disease, and may internalize their feelings and manifest symptoms," Kirsner said.

This suggests "more aggressive, expert treatment for even mild eczema might improve the lives of children, and has potential for longer term mental health benefits," he added.

What can parents do?

Abuabara said they should strive to get the best care possible, not only for eczema itself but for the emotional hardship it may trigger.

"If you have a child with eczema that you're concerned about, it is important to talk to their doctor about optimizing their eczema treatment and to ask about behavioral screening and support through their clinic and/or school," Abuabara said.

The findings appear in the Sept. 1 online edition of JAMA Dermatology.

More information

There's more on eczema at the National Eczema Association.

SOURCES: Katrina Abuabara, MD, MSCE, associate professor, dermatology, University of California, San Francisco, and associate adjunct professor of epidemiology, University of California, Berkeley School of Public Health; Robert Kirsner, MD, PhD, chairman and professor, department of dermatology and cutaneous surgery, University of Miami Miller School of Medicine, and director, University of Miami Hospital and Clinics Wound Center; JAMA Dermatology, Sept. 1, 2021, online